Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning. / Zucco, Adrian G.; Agius, Rudi; Svanberg, Rebecka; Moestrup, Kasper S.; Marandi, Ramtin Z.; MacPherson, Cameron Ross; Lundgren, Jens; Ostrowski, Sisse R.; Niemann, Carsten U.

I: Scientific Reports, Bind 12, 13879, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Zucco, AG, Agius, R, Svanberg, R, Moestrup, KS, Marandi, RZ, MacPherson, CR, Lundgren, J, Ostrowski, SR & Niemann, CU 2022, 'Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning', Scientific Reports, bind 12, 13879. https://doi.org/10.1038/s41598-022-17953-y

APA

Zucco, A. G., Agius, R., Svanberg, R., Moestrup, K. S., Marandi, R. Z., MacPherson, C. R., Lundgren, J., Ostrowski, S. R., & Niemann, C. U. (2022). Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning. Scientific Reports, 12, [13879]. https://doi.org/10.1038/s41598-022-17953-y

Vancouver

Zucco AG, Agius R, Svanberg R, Moestrup KS, Marandi RZ, MacPherson CR o.a. Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning. Scientific Reports. 2022;12. 13879. https://doi.org/10.1038/s41598-022-17953-y

Author

Zucco, Adrian G. ; Agius, Rudi ; Svanberg, Rebecka ; Moestrup, Kasper S. ; Marandi, Ramtin Z. ; MacPherson, Cameron Ross ; Lundgren, Jens ; Ostrowski, Sisse R. ; Niemann, Carsten U. / Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning. I: Scientific Reports. 2022 ; Bind 12.

Bibtex

@article{53e37eec92414c6c8ca00ac0309e0a49,
title = "Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning",
abstract = "Interpretable risk assessment of SARS-CoV-2 positive patients can aid clinicians to implement precision medicine. Here we trained a machine learning model to predict mortality within 12 weeks of a first positive SARS-CoV-2 test. By leveraging data on 33,938 confirmed SARS-CoV-2 cases in eastern Denmark, we considered 2723 variables extracted from electronic health records (EHR) including demographics, diagnoses, medications, laboratory test results and vital parameters. A discrete-time framework for survival modelling enabled us to predict personalized survival curves and explain individual risk factors. Performance on the test set was measured with a weighted concordance index of 0.95 and an area under the curve for precision-recall of 0.71. Age, sex, number of medications, previous hospitalizations and lymphocyte counts were identified as top mortality risk factors. Our explainable survival model developed on EHR data also revealed temporal dynamics of the 22 selected risk factors. Upon further validation, this model may allow direct reporting of personalized survival probabilities in routine care.",
author = "Zucco, {Adrian G.} and Rudi Agius and Rebecka Svanberg and Moestrup, {Kasper S.} and Marandi, {Ramtin Z.} and MacPherson, {Cameron Ross} and Jens Lundgren and Ostrowski, {Sisse R.} and Niemann, {Carsten U.}",
note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
doi = "10.1038/s41598-022-17953-y",
language = "English",
volume = "12",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning

AU - Zucco, Adrian G.

AU - Agius, Rudi

AU - Svanberg, Rebecka

AU - Moestrup, Kasper S.

AU - Marandi, Ramtin Z.

AU - MacPherson, Cameron Ross

AU - Lundgren, Jens

AU - Ostrowski, Sisse R.

AU - Niemann, Carsten U.

N1 - Publisher Copyright: © 2022, The Author(s).

PY - 2022

Y1 - 2022

N2 - Interpretable risk assessment of SARS-CoV-2 positive patients can aid clinicians to implement precision medicine. Here we trained a machine learning model to predict mortality within 12 weeks of a first positive SARS-CoV-2 test. By leveraging data on 33,938 confirmed SARS-CoV-2 cases in eastern Denmark, we considered 2723 variables extracted from electronic health records (EHR) including demographics, diagnoses, medications, laboratory test results and vital parameters. A discrete-time framework for survival modelling enabled us to predict personalized survival curves and explain individual risk factors. Performance on the test set was measured with a weighted concordance index of 0.95 and an area under the curve for precision-recall of 0.71. Age, sex, number of medications, previous hospitalizations and lymphocyte counts were identified as top mortality risk factors. Our explainable survival model developed on EHR data also revealed temporal dynamics of the 22 selected risk factors. Upon further validation, this model may allow direct reporting of personalized survival probabilities in routine care.

AB - Interpretable risk assessment of SARS-CoV-2 positive patients can aid clinicians to implement precision medicine. Here we trained a machine learning model to predict mortality within 12 weeks of a first positive SARS-CoV-2 test. By leveraging data on 33,938 confirmed SARS-CoV-2 cases in eastern Denmark, we considered 2723 variables extracted from electronic health records (EHR) including demographics, diagnoses, medications, laboratory test results and vital parameters. A discrete-time framework for survival modelling enabled us to predict personalized survival curves and explain individual risk factors. Performance on the test set was measured with a weighted concordance index of 0.95 and an area under the curve for precision-recall of 0.71. Age, sex, number of medications, previous hospitalizations and lymphocyte counts were identified as top mortality risk factors. Our explainable survival model developed on EHR data also revealed temporal dynamics of the 22 selected risk factors. Upon further validation, this model may allow direct reporting of personalized survival probabilities in routine care.

U2 - 10.1038/s41598-022-17953-y

DO - 10.1038/s41598-022-17953-y

M3 - Journal article

C2 - 35974050

AN - SCOPUS:85135990651

VL - 12

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 13879

ER -

ID: 319804358